Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Aligos Therapeutics
ALGS
$43.7M
| $4.86M | ﹤0.01% |
12,546
+2,332
| +23% | +$922K |
|
2927
Citizens
CIA
$199M
| $4.86M | ﹤0.01% |
783,412
+9,578
| +1% | +$54.4K |
|
2928
Vertex
VERX
$2.15B
| $4.86M | ﹤0.01% |
253,048
+19,169
| +8% | +$371K |
|
2929
Cogent Biosciences
COGT
$6.47B
| $4.86M | ﹤0.01% |
577,764
+3,895
| +0.7% | +$29.8K |
|
|
NESR
2930
National Energy Services Reunited Corp
NESR
$3.62B
| $4.84M | ﹤0.01% |
386,467
+60,743
| +19% | +$739K |
|
2931
The Honest Company
HNST
$540M
| $4.83M | ﹤0.01% |
465,510
+10,460
| +2% | +$128K |
|
|
SRTA
2932
Strata Critical Medical Inc
SRTA
$533M
| $4.82M | ﹤0.01% |
463,916
-3,289
| -0.7% | -$28.7K |
|
2933
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $4.8M | ﹤0.01% |
178,253
+13,376
| +8% | +$357K |
|
2934
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| – | – |
0
| – | – |
|
2935
Alta Equipment Group
ALTG
$254M
| $4.76M | ﹤0.01% |
346,624
+12,653
| +4% | +$166K |
|
2936
United States Lime & Minerals
USLM
$3.42B
| $4.73M | ﹤0.01% |
195,895
+8,270
| +4% | +$230K |
|
|
PCSB
2937
DELISTED
PCSB Financial Corporation
PCSB
| $4.73M | ﹤0.01% |
256,494
-4,782
| -2% | -$87.3K |
|
2938
Passage Bio
PASG
$14.8M
| $4.71M | ﹤0.01% |
23,666
-2,789
| -11% | -$665K |
|
|
NMTR
2939
DELISTED
9 Meters Biopharma
NMTR
| $4.71M | ﹤0.01% |
181,203
+12,528
| +7% | +$295K |
|
2940
Greif Class B
GEF.B
$4.24B
| $4.68M | ﹤0.01% |
72,259
+2,873
| +4% | +$177K |
|
|
LITS
2941
Lite Strategy Inc
LITS
$31.4M
| $4.68M | ﹤0.01% |
84,732
+1,598
| +2% | +$88K |
|
2942
Stereotaxis
STXS
$137M
| $4.68M | ﹤0.01% |
869,452
-14,545
| -2% | -$110K |
|
2943
FS Bancorp
FSBW
$325M
| $4.67M | ﹤0.01% |
135,054
-1,320
| -1% | -$45.3K |
|
2944
Remitly
RELY
$5.39B
| $4.66M | ﹤0.01% |
+127,040
| New | +$5.19M |
|
2945
Sony
SONY
$138B
| $4.63M | ﹤0.01% |
209,615
-28,405
| -12% | -$595K |
|
|
BFX
2946
DELISTED
BowFlex Inc.
BFX
| $4.63M | ﹤0.01% |
497,624
-1,704
| -0.3% | -$21.9K |
|
2947
BARK
BARK
$96.3M
| $4.63M | ﹤0.01% |
+33,746
| New | +$5.56M |
|
2948
Elbit Systems
ESLT
$36.5B
| $4.62M | ﹤0.01% |
31,911
+587
| +2% | +$81.1K |
|
2949
Matrix Service
MTRX
$330M
| $4.62M | ﹤0.01% |
441,866
-13,224
| -3% | -$142K |
|
2950
Toyota
TM
$223B
| $4.62M | ﹤0.01% |
25,995
-1,551
| -6% | -$277K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.